Kenes Group

In this interview, Anastasia Albanese‑O’Neill and Sanjoy Dutta share the thinking behind the inaugural Breakthrough T1D Clinical & Research Congress, a new global forum designed to connect clinicians, researchers, industry leaders, and advocates working to improve lives and accelerate progress toward a cure.

The conversation highlights the importance of alignment, collaboration, and shared purpose across the T1D ecosystem.
🎥 Watch the video interview and hear their insights: https://www.citybiz.co/article/846782/edwin-warfield-interviews-anastasia-albanese-oneill-vp-of-medical-affairs-and-sanjoy-dutta-chief-scientific-officer-at-breakthrough-t1d/

Taking place 9–11 October 2026 in Philadelphia, the Congress will bring together the full spectrum of expertise across care, research, and innovation to help turn ideas into impact. Kenes Group is proud to support this initiative as Congress organiser.

✨

Edwin Warfield Interviews Anastasia Albanese-O’Neill, VP of Medical Affairs and Sanjoy Dutta, Chief Scientific Officer at Breakthrough T1D About the Inaugural Breakthrough T1D Clinical & Research Congress Anastasia Albanese-O’Neill, Ph.D. – VP of Medical Affairs, Breakthrough T1D Anastasia Albanese-O’Neill, Ph.D., APRN, CDCES, serves as vice president, medical... Read More

📣 Tomorrow: Global Growth Reimagined | Free Webinar

A final reminder to join us for a forward‑looking discussion on how associations can turn disruption into new revenue opportunities.

In this session, we’ll share practical frameworks you can apply immediately, covering:
• AI‑enabled membership growth
• Hybrid meeting ROI
• Global non‑dues revenue diversification

🎙 Speakers: Jeanne Sheehy, Peter Doherty (BostromAMC), Avital Rosen Topel and Louise Gorringe (Kenes Group)

📅 Tuesday, 9 June
🕔 17:00 CET | 10:00 CT
🎥 Complimentary to attend

👉 Register here: https://amc-webinar.com/